Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine added to propofol sedation for cataract surgery
IRCT138812223520N2Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine and propofol in cataract (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Hemodynamic changes and Recovery time. Started Oct 2010; status: completed.
02
Drugs
ketaminepropofol
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT138812223520N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138812223520N2.